Cases 1 - 10 of 29
Nivagen, Inc. v. Sun Pharmaceuticals Industries, Inc. et al
as 2:2024cv00036
Plaintiff:
Nivagen, Inc.
Defendant:
Sun Pharmaceuticals Industries, Inc., Sun Pharmaceutical Industries Ltd., Sun Pharma Advanced Research Company Ltd. and others
Cause Of Action: 28 U.S.C. § 1331 Fed. Question
Par Pharmaceutical, Inc. et al v. Mankind Pharma Limited
as 2:2023cv00399
Plaintiff:
Par Pharmaceutical, Inc. and Endo Par Innovation Company, LLC
Defendant:
Mankind Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Metuchen Pharmaceuticals LLC et al v. Empower Pharmaceuticals LLC et al
as 4:2018cv04344
Defendant:
Empower Clinic Services LLC, Arta S Noorian, Shaun Noorian and others
Plaintiff:
Metuchen Pharmaceuticals LLC and Mitsubishi Tanabe Pharma Corporation
Cause Of Action: 15 U.S.C. § 1126
Promius Pharma LLC v. Perrigo UK FINCO Limited Partnership et al
as 2:2018cv00219
Plaintiff:
Promius Pharma LLC
Defendant:
Perrigo UK FINCO Limited Partnership , Perrigo Israel Pharmaceuticals Ltd. and Taro Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Nexgen Pharma, Inc. v. SciLife Biosciences, LLC et al
as 4:2018cv00299
Plaintiff:
Nexgen Pharma, Inc.
Defendant:
SciLife Biosciences, LLC and Jacob Rosenstein
Cause Of Action: 15 U.S.C. § 1051
Horizon Pharma, Inc. et al v. Dr. Reddy's Laboratories Inc. et al
as 1:2017mc00997
Movant:
Baker Botts LLP and Stephen M. Hash
Defendant:
Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd., Lupin Ltd. and others
Respondent:
Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories Ltd.
Plaintiff:
Horizon Pharma, Inc. and Pozen Inc.
Cause Of Action: Motion to Quash
Horizon Pharma, Inc. et al v. Dr. Reddy's Laboratories Inc. et al
as 1:2017cv00997
Defendant:
Dr. Reddy's Laboratories Ltd., Mylan Pharmaceuticals Inc., Lupin Ltd. and others
Petitioner:
Stephen M. Hash and Baker Botts LLP
Plaintiff:
Horizon Pharma, Inc. and Pozen Inc.
Galderma Laboratories LP et al v SEEGPharm SA
as 3:2016cv02497
Plaintiff:
Galderma Laboratories LP , Galderma Pharma SA and Dow Pharmaceutical Sciences Inc
Defendant:
SEEGPharm SA
Cause Of Action: 35 U.S.C. § 271
United States, et al v. Cytogel Pharma, LLC
as 2:2016cv13987
Plaintiff:
The Administrators of the Tulane Educational Fund, United States, Administrators of the Tulane Educational Fund and others
Defendant:
Cytogel Pharma, LLC
Counter Defendant:
James E Zadina
Cause Of Action: 28 U.S.C. § 2201 Declaratory Judgment
Mylan Institutional LLC et al v. Aurobindo Pharma Ltd et al
as 2:2016cv00491
Plaintiff:
Mylan Institutional LLC and Apicore US LLC
Defendant:
Aurobindo Pharma Ltd , Aurobindo Pharma USA Inc. and AuroMedics Pharma LLC
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
